JAPAN > US based Amgen to redeem Kirin’s shares the JV Kirin- Amgen making Kirin- Amgen a wholly-owned subsidiary of Amgen

Amgen logo Both Amgen and Kirin Holdings have agreed that Kirin-Amgen’s, Kirin shares will be bought by Amgen making Kirin- Amgen a wholly- owned subsidiary of Amgen. Established in 1984 as a 50-50 joint venture between Amgen and Kirin to fund the development of EPOGEN® (epoetin alfa) and later NEUPOGEN®(filgrastim), Neulasta® (pegfilgrastim), Aranesp® (darbepoetin alfa), Nplate® (romiplostim) and brodalumab. Kirin-Amgen also holds the intellectual property of More …